CIK 0001380106
- Emerging growth company
RAPID MICRO BIOSYSTEMS, INC.
Sign in to watch- Ticker
- RPID
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208121647
- Phone
- +1 978-349-3200
- Business address
- 25 HARTWELL AVENUE, LEXINGTON, MA, 02421
- Former names
- RAPID MICRO BIOSYSTEMS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 60,100 shares at an average $4.72 ($283,597)
- 4 Open-market buy 10% owner bought 68,617 shares at an average $4.87 ($334,441)
- 4 Open-market buy 10% owner bought 49,883 shares at an average $4.59 ($228,874)
- 4 Open-market buy 10% owner bought 96,516 shares at an average $4.08 ($393,795)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 10,000 shares at $3.80 ($37,950)
- 4 Exercise or conversion Chief Financial Officer acquired 10,000 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 35,000 shares (option exercise)
- 4 Open-market buy Director bought 10,000 shares at $6.95 ($69,500)
- 4 Grant or award Chief Operating Officer acquired 61,250 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 40,000 shares (grant or award)
- 4 Grant or award Chief Human Resources Officer acquired 28,750 shares (grant or award)
- 4 Grant or award Senior VP and General Counsel acquired 43,750 shares (grant or award)
- 4 Grant or award President and CEO acquired 98,750 shares (grant or award)
- 4 Grant or award CHIEF COMMERCIAL OFFICER acquired 43,750 shares (grant or award)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 8 · 150 filings